Non-Invasive Photoacoustic Imaging of In Vivo Mice with Erythrocyte Derived Optical Nanoparticles to Detect CAD/MI

Yonggang Liu, Taylor Hanley, Hao Chen, Steven Long, Sanjiv S. Gambhir, Zhen Cheng, Joseph C. Wu, Georges El Fakhri, Bahman Anvari, Raiyan T. ZamanScientific 2020 · DOI

TL;DR

Researchers engineered biocompatible nanoparticles from red blood cell "ghosts" to act as contrast agents for photoacoustic imaging. When tested in mice, these particles successfully localized at sites of arterial injury and inflammation, providing a high-resolution, non-invasive way to detect coronary artery disease and myocardial infarction with a 256-fold signal enhancement.

Abstract

Coronary artery disease (CAD) causes mortality and morbidity worldwide. We used near-infrared erythrocyte-derived transducers (NETs), a contrast agent, in combination with a photoacoustic imaging system to identify the locations of atherosclerotic lesions and occlusion due to myocardial-infarction (MI). NETs (≈90 nm diameter) were fabricated from hemoglobin-depleted mice erythrocyte-ghosts and doped with Indocyanine Green (ICG). Ten weeks old male C57BL/6 mice (n = 9) underwent left anterior descending (LAD) coronary artery ligation to mimic vulnerable atherosclerotic plaques and their rupture leading to MI. 150 µL of NETs (20 µM ICG) was IV injected via tail vein 1-hour prior to photoacoustic (PA) and fluorescence in vivo imaging by exciting NETs at 800 nm and 650 nm, respectively. These results were verified with histochemical analysis. We observed ≈256-fold higher PA signal from the accumulated NETs in the coronary artery above the ligation. Fluorescence signals were detected in LAD coronary, thymus, and liver. Similar signals were observed when the chest was cut open. Atherosclerotic lesions exhibited inflammatory cells. Liver demonstrated normal portal tract, with no parenchymal necrosis, inflammation, fibrosis, or other pathologic changes, suggesting biocompatibility of NETs. Non-invasively detecting atherosclerotic plaques and stenosis using NETs may lay a groundwork for future clinical detection and improving CAD risk assessment.

Introduction

Coronary Artery Disease (CAD) remains a leading cause of global mortality, often remaining asymptomatic until a major cardiac event occurs. A primary challenge in cardiovascular diagnostics is the identification of "vulnerable plaques"—unstable arterial buildups that can rupture and cause myocardial infarction (MI) even without significantly obstructing blood flow. Current imaging modalities like CT, MRI, and X-ray angiography often fall short; they either lack the resolution to assess plaque burden or are invasive and provide only a silhouette of the vessel lumen rather than biological activity within the wall.

This study, published in Scientific Reports, introduces a non-invasive approach using biocompatible nanoparticles derived from red blood cells. These "Near-Infrared Erythrocyte-derived Transducers" (NETs) serve as contrast agents for photoacoustic (PA) imaging, enabling high-resolution visualization of arterial inflammation and blockages.

Methodology

The researchers developed a dual-modality imaging strategy combining the high contrast of optical imaging with the deep tissue penetration of ultrasound.

NETs Fabrication and Experimental Model

NETs were engineered from mouse erythrocyte "ghosts"—red blood cells stripped of hemoglobin—and extruded into ~90 nm nanoparticles. These particles were loaded with Indocyanine Green (ICG), a near-infrared dye. The study utilized a mouse model where the Left Anterior Descending (LAD) coronary artery was ligated to simulate the inflammation and tissue death characteristic of human MI.

Imaging Systems

The primary imaging tool was the Vevo-LAZR Photoacoustic Imaging System. This system uses laser pulses to excite the NETs, which then emit ultrasound waves through thermoelastic expansion. This allows for imaging through several centimeters of tissue. Secondary validation was performed using the IVIS-200 Fluorescence Imaging System to track the biodistribution of the nanoparticles.

Schematic and photographic representations of the (a) Vevo-LAZR photoacoustic imaging system and (b) IVIS-200 fluorescence imaging system used in the study.

The experimental cohort consisted of nine 10-week-old male C57BL/6 mice. Post-imaging, results were validated through extensive histological analysis of heart and liver tissues to confirm particle localization and assess biocompatibility.

Key Results and Insights

The study demonstrated that NETs act as a "Trojan Horse," evading the immune system long enough to accumulate at sites of arterial injury, where they are internalized by macrophages.

  • Significant Signal Enhancement: The researchers recorded a 256-fold increase in the PA signal at the ligation site compared to healthy heart tissue. This positive contrast clearly highlighted the "hot zone" of inflammation.
  • Depth and Resolution: By converting light into sound, the PA system successfully bypassed the ribcage and overlying tissue, providing clear images of the heart at depths that typically hinder pure optical methods.
  • Biocompatibility: Histology of the liver and other organs showed no signs of toxicity, necrosis, or inflammation, indicating that the erythrocyte-derived particles are safe and well-tolerated.
  • Optimal Loading: The study identified 20 µM ICG as the optimal concentration for NETs; higher concentrations led to fluorescence quenching due to molecular aggregation.

Discussion and Future Directions

While these results are a significant step toward non-invasive CAD detection, several challenges remain for clinical translation. The scale of a human chest requires even deeper signal penetration and more sensitive transducers than those used in the mouse model. Additionally, the high heart rate of humans necessitates advanced motion-correction algorithms to prevent artifacts; the Vevo-LAZR system used here achieves high frame rates (740 fps), but scaling this to human anatomy is a non-trivial task.

Future research will focus on testing this platform in larger animal models (e.g., rabbits or pigs) and developing automated 3D quantification methods to better evaluate the severity of arterial blockages. This technology lays the groundwork for a new generation of non-invasive tools for early CAD risk assessment and diagnosis.

Summary updated

Abstract

Coronary artery disease (CAD) causes mortality and morbidity worldwide. We used near-infrared erythrocyte-derived transducers (NETs), a contrast agent, in combination with a photoacoustic imaging system to identify the locations of atherosclerotic lesions and occlusion due to myocardial-infarction (MI). NETs (≈90 nm diameter) were fabricated from hemoglobin-depleted mice erythrocyte-ghosts and doped with Indocyanine Green (ICG). Ten weeks old male C57BL/6 mice (n = 9) underwent left anterior descending (LAD) coronary artery ligation to mimic vulnerable atherosclerotic plaques and their rupture leading to MI. 150 µL of NETs (20 µM ICG,) was IV injected via tail vein 1-hour prior to photoacoustic (PA) and fluorescence in vivo imaging by exciting NETs at 800 nm and 650 nm, respectively. These results were verified with histochemical analysis. We observed ≈256-fold higher PA signal from the accumulated NETs in the coronary artery above the ligation. Fluorescence signals were detected in LAD coronary, thymus, and liver. Similar signals were observed when the chest was cut open. Atherosclerotic lesions exhibited inflammatory cells. Liver demonstrated normal portal tract, with no parenchymal necrosis, inflammation, fibrosis, or other pathologic changes, suggesting biocompatibility of NETs. Non-invasively detecting atherosclerotic plaques and stenosis using NETs may lay a groundwork for future clinical detection and improving CAD risk assessment.
BibTeX
@inproceedings{liu2020non,
  author = {Yonggang Liu and Taylor Hanley and Hao Chen and Steven Long and Sanjiv S. Gambhir and Zhen Cheng and Joseph C. Wu and Georges El Fakhri and Bahman Anvari and Raiyan T. Zaman},
  title = {{Non-Invasive Photoacoustic Imaging of In Vivo Mice with Erythrocyte Derived Optical Nanoparticles to Detect CAD/MI}},
  booktitle = {Scientific},
  year = {2020},
  doi = {10.1038/s41598-020-62868-1},
}
Figure